Financhill
Buy
55

GILD Quote, Financials, Valuation and Earnings

Last price:
$97.87
Seasonality move :
6.99%
Day range:
$102.46 - $103.85
52-week range:
$62.07 - $119.96
Dividend yield:
3.02%
P/E ratio:
21.64x
P/S ratio:
4.51x
P/B ratio:
6.71x
Volume:
5.5M
Avg. volume:
9.1M
1-year change:
58.71%
Market cap:
$128B
Revenue:
$28.8B
EPS (TTM):
$4.75

Earnings Data

Next earnings date for GILD
Aug 08
2025
Most recent earnings per share
$1.04
Missed by $0.73
(Apr 24/2025)
Consensus Estimate
$1.77
(Apr 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GILD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $7B -- -- $1.95 --
04/24/2025 Q1 $6.8B $6.7B $1.04 $1.77 -$0.73
02/11/2025 Q4 $7.2B $7.6B $1.42 $1.70 -$0.28
11/06/2024 Q3 $7B $7.5B $1.00 $1.55 -$0.55
08/08/2024 Q2 $6.7B $7B $1.29 $1.60 -$0.31
04/25/2024 Q1 $6.3B $6.7B -$3.34 -$1.52 -$1.82
02/06/2024 Q4 $7.1B $7.1B $1.14 $1.76 -$0.62
11/07/2023 Q3 -- -- $1.73 $1.92 -$0.19
08/03/2023 Q2 -- -- $0.83 $1.64 -$0.81
04/27/2023 Q1 -- -- $0.80 $1.54 -$0.74
02/02/2023 Q4 -- -- $1.30 $1.51 -$0.21
10/27/2022 Q3 -- -- $1.42 $1.43 -$0.01
08/02/2022 Q2 -- -- $0.91 $1.52 -$0.61
04/28/2022 Q1 -- -- $0.02 $1.81 -$1.79
02/01/2022 Q4 -- -- $0.30 $1.61 -$1.31
10/28/2021 Q3 -- -- $2.05 $1.78 $0.27
07/29/2021 Q2 -- -- $1.21 $1.75 -$0.54
04/29/2021 Q1 -- -- $1.37 $2.11 -$0.74
02/04/2021 Q4 -- -- $1.23 $2.15 -$0.92
10/28/2020 Q3 -- -- $0.29 $1.89 -$1.60
07/30/2020 Q2 -- -- -$2.66 $1.45 -$4.11
04/30/2020 Q1 -- -- $1.22 $1.56 -$0.34
02/04/2020 Q4 -- -- $2.12 $1.67 $0.45
10/24/2019 Q3 -- -- -$0.92 $1.73 -$2.65
07/30/2019 Q2 -- -- $1.82 $1.71 $0.11
05/02/2019 Q1 -- -- $1.76 $1.60 $0.16
02/04/2019 Q4 -- -- $1.44 $1.69 -$0.25
10/25/2018 Q3 -- -- $1.84 $1.63 $0.21
07/25/2018 Q2 -- -- $1.91 $1.56 $0.35
05/01/2018 Q1 -- -- $1.48 $1.67 -$0.19
02/06/2018 Q4 -- -- $1.78 $1.67 $0.11
10/26/2017 Q3 -- -- $2.27 $2.13 $0.14
07/26/2017 Q2 -- -- $2.56 $2.17 $0.39
05/02/2017 Q1 -- -- $2.23 $2.28 -$0.05
02/07/2017 Q4 -- -- $2.64 $2.31 $0.33
11/01/2016 Q3 -- -- $2.70 $2.74 -$0.04
07/25/2016 Q2 -- -- $3.03 $3.02 $0.01
04/28/2016 Q1 -- -- $2.98 $3.03 -$0.05
02/02/2016 Q4 -- -- $3.27 $2.91 $0.36
10/27/2015 Q3 -- -- $3.19 $3.03 $0.16
07/28/2015 Q2 -- -- $3.10 $2.83 $0.27

Gilead Sciences Earnings Questions

  • How Much did Gilead Sciences Generate in Revenue Last Quarter?

    Gilead Sciences reported $6.7B worth of top line sales in its most recent quarter.

  • Did Gilead Sciences Beat Earnings Last Quarter?

    Gilead Sciences announced earnings per share of $1.04 which represents a miss of analyst forecast a $1.77 per share.

  • Is Gilead Sciences Profitable?

    Gilead Sciences reported $5.1B that represents $4.07 per share over the last quarter.

  • What is the Analyst Consensus for Gilead Sciences EPS Next Year?

    Gilead Sciences's earnings are forecast to grow from $0.38 per share to $4.41 per share next year representing an increase of 1999.14%.

  • When is Gilead Sciences's Earnings Date?

    Gilead Sciences's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock